Ginsenoside Rg1 treatment alleviates renal fibrosis by inhibiting the NOX4–MAPK pathway in T2DM mice

References

• DeFronzo RA, Ferrannini E, Zimmet P, et al. International textbook of diabetes mellitus. 4th ed. Chichester (UK): John Wiley & Sons, Ltd; 2015.
   Google Scholar
• Lovic D, Piperidou A, Zografou I, et al. The growing epidemic of diabetes mellitus. Curr Vasc Pharmacol. 2020;18(2):104–109.
   PubMed Web of Science ®Google Scholar
• Thomas MC, Brownlee M, Susztak K, et al. Diabetic kidney disease. Nat Rev Dis Primers. 2015;1:15018.
   PubMed Web of Science ®Google Scholar
• Anders HJ, Huber TB, Isermann B, et al. CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease. Nat Rev Nephrol. 2018;14(6):361–377.
   PubMed Web of Science ®Google Scholar
• Tervaert TW, Mooyaart AL, Amann K, et al. Pathologic classification of diabetic nephropathy. J Am Soc Nephrol. 2010;21(4):556–563.
   PubMed Web of Science ®Google Scholar
• Kolset SO, Reinholt FP, Jenssen T. Diabetic nephropathy and extracellular matrix. J Histochem Cytochem. 2012;60(12):976–986.
   PubMed Web of Science ®Google Scholar
• Qiao S, Liu R, Lv C, et al. Bergenin impedes the generation of extracellular matrix in glomerular mesangial cells and ameliorates diabetic nephropathy in mice by inhibiting oxidative stress via the mTOR/beta-TrcP/Nrf2 pathway. Free Radic Biol Med. 2019;145:118–135.
   PubMed Web of Science ®Google Scholar
• Ge Y, Wang J, Wu D, et al. lncRNA NR_038323 suppresses renal fibrosis in diabetic nephropathy by targeting the miR-324-3p/DUSP1 axis. Mol Ther Nucleic Acids. 2019;17:741–753.
   PubMedGoogle Scholar
• Huang H, Ni H, Ma K, et al. ANGPTL2 regulates autophagy through the MEK/ERK/Nrf-1 pathway and affects the progression of renal fibrosis in diabetic nephropathy. Am J Transl Res. 2019;11(9):5472–5486.
   PubMed Web of Science ®Google Scholar
• Malik S, Suchal K, Khan SI, et al. Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-kappaB-TNF-alpha and TGF-beta1-MAPK-fibronectin pathways. Am J Physiol Renal Physiol. 2017;313(2):F414–F422.
   PubMed Web of Science ®Google Scholar
• Warren AM, Knudsen ST, Cooper ME. Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies. Expert Opin Ther Targets. 2019;23(7):579–591.
   PubMed Web of Science ®Google Scholar
• Kim JY, Bacha F, Tfayli H, et al. Adipose tissue insulin resistance in youth on the spectrum from normal weight to obese and from normal glucose tolerance to impaired glucose tolerance to type 2 diabetes. Diabetes Care. 2019;42(2):265–272.
   PubMed Web of Science ®Google Scholar
• Chou YJ, Kan WC, Chang CM, et al. Renal protective effects of low molecular weight of inonotus obliquus polysaccharide (LIOP) on HFD/STZ-Induced nephropathy in mice. Int J Mol Sci. 2016;17(9):1535.
   PubMed Web of Science ®Google Scholar
• Himanshu D, Ali W, Wamique M. Type 2 diabetes mellitus: pathogenesis and genetic diagnosis. J Diabetes Metab Disord. 2020;19(2):1959–1966.
   PubMed Web of Science ®Google Scholar
• Spiller S, Bluher M, Hoffmann R. Plasma levels of free fatty acids correlate with type 2 diabetes mellitus. Diabetes Obes Metab. 2018;20(11):2661–2669.
   PubMed Web of Science ®Google Scholar
• Ricciardi CA, Gnudi L. Kidney disease in diabetes: from mechanisms to clinical presentation and treatment strategies. Metabolism. 2021;124:154890.
   PubMed Web of Science ®Google Scholar
• Murphy MP, Bayir H, Belousov V, et al. Guidelines for measuring reactive oxygen species and oxidative damage in cells and in vivo. Nat Metab. 2022;4(6):651–662.
   PubMedGoogle Scholar
• Paneni F, Beckman JA, Creager MA, et al. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur Heart J. 2013;34(31):2436–2443.
   PubMed Web of Science ®Google Scholar
• Liang Y, Liu H, Fang Y, et al. Salvianolate ameliorates oxidative stress and podocyte injury through modulation of NOX4 activity in db/db mice. J Cell Mol Med. 2021;25(2):1012–1023.
   PubMed Web of Science ®Google Scholar
• Yang K, Bai Y, Yu N, et al. Huidouba improved podocyte injury by down-regulating Nox4 expression in rats with diabetic nephropathy. Front Pharmacol. 2020;11:587995.
   PubMed Web of Science ®Google Scholar
• Yuan Q, Tang B, Zhang C. Signaling pathways of chronic kidney diseases, implications for therapeutics. Signal Transduct Target Ther. 2022;7(1):182.
   PubMed Web of Science ®Google Scholar
• Ren Q, Guo F, Tao S, et al. Flavonoid fisetin alleviates kidney inflammation and apoptosis via inhibiting Src-mediated NF-kappaB p65 and MAPK signaling pathways in septic AKI mice. Biomed Pharmacother. 2020;122:109772.
   PubMed Web of Science ®Google Scholar
• Sedeek M, Callera G, Montezano A, et al. Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy. Am J Physiol Renal Physiol. 2010;299(6):F1348–F1358.
   PubMed Web of Science ®Google Scholar
• Zhang J, Yang S, Li H, et al. Naringin ameliorates diabetic nephropathy by inhibiting NADPH oxidase 4. Eur J Pharmacol. 2017;804:1–6.
   PubMed Web of Science ®Google Scholar
• Zhou T, Li S, Yang L, et al. microRNA-363-3p reduces endothelial cell inflammatory responses in coronary heart disease via inactivation of the NOX4-dependent p38 MAPK axis. Aging. 2021;13(8):11061–11082.
   PubMedGoogle Scholar
• Alolga RN, Nuer-Allornuvor GF, Kuugbee ED, et al. Ginsenoside Rg1 and the control of inflammation implications for the therapy of type 2 diabetes: a review of scientific findings and call for further research. Pharmacol Res. 2020;152:104630.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhang D, Li L, et al. Ginsenoside Rg1 ameliorates aging‑induced liver fibrosis by inhibiting the NOX4/NLRP3 inflammasome in SAMP8 mice. Mol Med Rep. 2021;24(5):801.
   PubMed Web of Science ®Google Scholar
• Shen X, Dong X, Han Y, et al. Ginsenoside Rg1 ameliorates glomerular fibrosis during kidney aging by inhibiting NOX4 and NLRP3 inflammasome activation in SAMP8 mice. Int Immunopharmacol. 2020;82:106339.
   PubMed Web of Science ®Google Scholar
• Fan X, Tao J, Zhou Y, et al. Investigations on the effects of ginsenoside-Rg1 on glucose uptake and metabolism in insulin resistant HepG2 cells. Eur J Pharmacol. 2019;843:277–284.
   PubMed Web of Science ®Google Scholar
• Liu H, Chen W, Lu P, et al. Ginsenoside Rg1 attenuates the inflammation and oxidative stress induced by diabetic nephropathy through regulating the PI3K/AKT/FOXO3 pathway. Ann Transl Med. 2021;9(24):1789.
   PubMed Web of Science ®Google Scholar
• Furman BL. Streptozotocin-induced diabetic models in mice and rats. Curr Protoc. 2021;1(4):e78.
   PubMedGoogle Scholar
• Cheng X, He S, Yuan J, et al. Lipoxin A4 attenuates LPS-induced mouse acute lung injury via Nrf2-mediated E-cadherin expression in airway epithelial cells. Free Radic Biol Med. 2016;93:52–66.
   PubMed Web of Science ®Google Scholar
• Oparka M, Walczak J, Malinska D, et al. Quantifying ROS levels using CM-H(2)DCFDA and HyPer. Methods. 2016;109:3–11.
   PubMed Web of Science ®Google Scholar
• Mehlem A, Hagberg CE, Muhl L, et al. Imaging of neutral lipids by oil red O for analyzing the metabolic status in health and disease. Nat Protoc. 2013;8(6):1149–1154.
   PubMed Web of Science ®Google Scholar
• Chen K, Dai H, Yuan J, et al. Optineurin-mediated mitophagy protects renal tubular epithelial cells against accelerated senescence in diabetic nephropathy. Cell Death Dis. 2018;9(2):105.
   PubMedGoogle Scholar
• Wolf P, Winhofer Y, Anderwald CH, et al. Intracellular lipid accumulation and shift during diabetes progression. Wien Med Wochenschr. 2014;164(15-16):320–329.
   PubMedGoogle Scholar
• Li S, Zheng L, Zhang J, et al. Inhibition of ferroptosis by up-regulating Nrf2 delayed the progression of diabetic nephropathy. Free Radic Biol Med. 2021;162:435–449.
   PubMed Web of Science ®Google Scholar
• Yang Q, Wu FR, Wang JN, et al. Nox4 in renal diseases: an update. Free Radic Biol Med. 2018;124:466–472.
   PubMed Web of Science ®Google Scholar
• Zhang J, Wang X, Vikash V, et al. ROS and ROS-mediated cellular signaling. Oxid Med Cell Longev. 2016;2016:4350965.
   PubMed Web of Science ®Google Scholar
• GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204–1222.
   PubMed Web of Science ®Google Scholar
• Sagoo MK, Gnudi L. Diabetic nephropathy: an overview. Methods Mol Biol. 2020;2067:3–7.
   PubMedGoogle Scholar
• Zhang D, Ji P, Sun R, et al. Ginsenoside Rg1 attenuates LPS-induced chronic renal injury by inhibiting NOX4-NLRP3 signaling in mice. Biomed Pharmacother. 2022;150:112936.
   PubMed Web of Science ®Google Scholar
• Wei X, Chen Y, Huang W. Ginsenoside Rg1 ameliorates liver fibrosis via suppressing epithelial to mesenchymal transition and reactive oxygen species production in vitro and in vivo. Biofactors. 2018.
   Google Scholar
• Waanders F, van Timmeren MM, Stegeman CA, et al. Kidney injury molecule-1 in renal disease. J Pathol. 2010;220(1):7–16.
   PubMed Web of Science ®Google Scholar
• Liu L, Xia R, Song X, et al. Association between the triglyceride-glucose index and diabetic nephropathy in patients with type 2 diabetes: a cross-sectional study. J Diabetes Investig. 2021;12(4):557–565.
   PubMed Web of Science ®Google Scholar
• Lu J, Liu X, Jiang S, et al. Body mass index and risk of diabetic nephropathy: a Mendelian randomization study. J Clin Endocrinol Metab. 2022;107(6):1599–1608.
   PubMed Web of Science ®Google Scholar
• Sobczak AIS, Blindauer CA, Stewart AJ. Changes in plasma free fatty acids associated with type-2 diabetes. Nutrients. 2019;11(9):2022.
   PubMed Web of Science ®Google Scholar
• Liu Y, Li Y, Shen H, et al. Association between the metabolic profile of serum fatty acids and diabetic nephropathy: a study conducted in northeastern China. Ther Adv Endocrinol Metab. 2022;13:20420188221118750.
   Web of Science ®Google Scholar
• Song Y, Sondergaard E, Jensen MD. Unique metabolic features of adults discordant for indices of insulin resistance. J Clin Endocrinol Metab. 2020;105(8):e2753–e2763.
   PubMed Web of Science ®Google Scholar
• Chen Q, Su Y, Ju Y, et al. Astragalosides IV protected the renal tubular epithelial cells from free fatty acids-induced injury by reducing oxidative stress and apoptosis. Biomed Pharmacother. 2018;108:679–686.
   PubMed Web of Science ®Google Scholar
• Lee M, Zhao H, Liu X, et al. Protective effect of hydroxysafflor yellow A on nephropathy by attenuating oxidative stress and inhibiting apoptosis in induced type 2 diabetes in rat. Oxid Med Cell Longev. 2020;2020:7805393.
   PubMed Web of Science ®Google Scholar
• Sun Y, Ge X, Li X, et al. High-fat diet promotes renal injury by inducing oxidative stress and mitochondrial dysfunction. Cell Death Dis. 2020;11(10):914.
   PubMed Web of Science ®Google Scholar
• Lee JH, Massague J. TGF-beta in developmental and fibrogenic EMTs. Semin Cancer Biol. 2022;86(Pt 2):136–145.
   PubMedGoogle Scholar
• Holterman CE, Read NC, Kennedy CR. Nox and renal disease. Clin Sci. 2015;128(8):465–481.
   Web of Science ®Google Scholar
• Munoz M, Lopez-Oliva ME, Rodriguez C, et al. Differential contribution of Nox1, Nox2 and Nox4 to kidney vascular oxidative stress and endothelial dysfunction in obesity. Redox Biol. 2020;28:101330.
   PubMed Web of Science ®Google Scholar
• Du Y, Xiao H, Wan J, et al. Atorvastatin attenuates TGF‑beta1‑induced fibrogenesis by inhibiting Smad3 and MAPK signaling in human ventricular fibroblasts. Int J Mol Med. 2020;46(2):633–640.
   PubMed Web of Science ®Google Scholar
• Xu Y, Zhang J, Fan L, et al. miR-423-5p suppresses high-glucose-induced podocyte injury by targeting Nox4. Biochem Biophys Res Commun. 2018;505(2):339–345.
   PubMed Web of Science ®Google Scholar
• Qi W, Niu J, Qin Q, et al. Glycated albumin triggers fibrosis and apoptosis via an NADPH oxidase/NOX4–MAPK pathway-dependent mechanism in renal proximal tubular cells. Mol Cell Endocrinol. 2015;405:74–83.
   PubMed Web of Science ®Google Scholar
• Li R, Guo Y, Zhang Y, et al. Salidroside ameliorates renal interstitial fibrosis by inhibiting the TLR4/NF-kappaB and MAPK signaling pathways. Int J Mol Sci. 2019;20(5):E1103.
   PubMed Web of Science ®Google Scholar
• Chen X, Wei W, Li Y, et al. Hesperetin relieves cisplatin-induced acute kidney injury by mitigating oxidative stress, inflammation and apoptosis. Chem Biol Interact. 2019;308:269–278.
   PubMed Web of Science ®Google Scholar
• Farkhondeh T, Mehrpour O, Buhrmann C, et al. Organophosphorus compounds and MAPK signaling pathways. Int J Mol Sci. 2020;21(12):E4258.
   PubMed Web of Science ®Google Scholar
• Wang H, Che J, Cui K, et al. Schisantherin A ameliorates liver fibrosis through TGF-beta1mediated activation of TAK1/MAPK and NF-kappaB pathways in vitro and in vivo. Phytomedicine. 2021;88:153609.
   PubMed Web of Science ®Google Scholar